USANA Health Sciences, Inc. (NYSE:USNA) Director Myron W. Wentz sold 17,107 shares of the business’s stock in a transaction dated Wednesday, November 1st. The stock was sold at an average price of $65.42, for a total transaction of $1,119,139.94. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink.

USANA Health Sciences, Inc. (NYSE USNA) opened at $64.85 on Friday. The firm has a market cap of $1,590.17, a price-to-earnings ratio of 17.21 and a beta of 1.07.

USANA Health Sciences (NYSE:USNA) last posted its earnings results on Tuesday, October 24th. The company reported $1.02 earnings per share for the quarter, beating the consensus estimate of $0.91 by $0.11. The company had revenue of $261.77 million for the quarter, compared to analyst estimates of $259.52 million. USANA Health Sciences had a net margin of 8.79% and a return on equity of 26.54%. USANA Health Sciences’s revenue was up 3.0% on a year-over-year basis. During the same period in the previous year, the business posted $2.40 EPS. sell-side analysts expect that USANA Health Sciences, Inc. will post 3.7 earnings per share for the current fiscal year.

USANA Health Sciences declared that its board has authorized a stock repurchase plan on Tuesday, July 25th that permits the company to repurchase $64.60 million in outstanding shares. This repurchase authorization permits the company to purchase up to 46% of its stock through open market purchases. Stock repurchase plans are often a sign that the company’s board of directors believes its stock is undervalued.

ILLEGAL ACTIVITY WARNING: “Myron W. Wentz Sells 17,107 Shares of USANA Health Sciences, Inc. (USNA) Stock” was posted by Watch List News and is the sole property of of Watch List News. If you are accessing this report on another website, it was illegally stolen and reposted in violation of US & international copyright and trademark laws. The legal version of this report can be accessed at https://www.watchlistnews.com/myron-w-wentz-sells-17107-shares-of-usana-health-sciences-inc-usna-stock/1677378.html.

USNA has been the topic of a number of recent research reports. Pivotal Research lowered their price target on shares of USANA Health Sciences from $75.00 to $70.00 and set a “buy” rating on the stock in a research report on Wednesday, July 26th. BidaskClub upgraded shares of USANA Health Sciences from a “sell” rating to a “hold” rating in a report on Thursday, October 26th.

A number of large investors have recently bought and sold shares of the business. Alps Advisors Inc. boosted its holdings in USANA Health Sciences by 0.3% in the 2nd quarter. Alps Advisors Inc. now owns 8,349 shares of the company’s stock valued at $535,000 after purchasing an additional 22 shares during the last quarter. California State Teachers Retirement System boosted its holdings in USANA Health Sciences by 0.5% in the 2nd quarter. California State Teachers Retirement System now owns 20,582 shares of the company’s stock valued at $1,319,000 after purchasing an additional 100 shares during the last quarter. JPMorgan Chase & Co. boosted its holdings in USANA Health Sciences by 1.2% in the 1st quarter. JPMorgan Chase & Co. now owns 16,044 shares of the company’s stock valued at $924,000 after purchasing an additional 196 shares during the last quarter. BNP Paribas Arbitrage SA boosted its holdings in USANA Health Sciences by 13.1% in the 2nd quarter. BNP Paribas Arbitrage SA now owns 2,111 shares of the company’s stock valued at $135,000 after purchasing an additional 245 shares during the last quarter. Finally, Legal & General Group Plc boosted its holdings in USANA Health Sciences by 7.6% in the 2nd quarter. Legal & General Group Plc now owns 4,040 shares of the company’s stock valued at $259,000 after purchasing an additional 284 shares during the last quarter. Institutional investors own 44.62% of the company’s stock.

About USANA Health Sciences

USANA Health Sciences, Inc develops and manufactures science-based nutritional and personal care products. The Company operates as a direct selling company in two geographic regions: Americas and Europe, and Asia Pacific, which includes three sub-regions: Southeast Asia Pacific, Greater China and North Asia.

Insider Buying and Selling by Quarter for USANA Health Sciences (NYSE:USNA)

Receive News & Ratings for USANA Health Sciences Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.